chr4-105276395-C-T
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBS1_Supporting
The NM_001127208.3(TET2):c.5885C>T(p.Pro1962Leu) variant causes a missense change. The variant allele was found at a frequency of 0.000523 in 1,551,790 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_001127208.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TET2 | NM_001127208.3 | c.5885C>T | p.Pro1962Leu | missense_variant | 11/11 | ENST00000380013.9 | NP_001120680.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TET2 | ENST00000380013.9 | c.5885C>T | p.Pro1962Leu | missense_variant | 11/11 | 5 | NM_001127208.3 | ENSP00000369351.4 |
Frequencies
GnomAD3 genomes AF: 0.000362 AC: 55AN: 152080Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000215 AC: 34AN: 157912Hom.: 0 AF XY: 0.000252 AC XY: 21AN XY: 83358
GnomAD4 exome AF: 0.000541 AC: 757AN: 1399710Hom.: 0 Cov.: 34 AF XY: 0.000532 AC XY: 367AN XY: 690338
GnomAD4 genome AF: 0.000362 AC: 55AN: 152080Hom.: 0 Cov.: 31 AF XY: 0.000431 AC XY: 32AN XY: 74302
ClinVar
Submissions by phenotype
not provided Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Jan 16, 2024 | BP4 - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 24, 2022 | This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 1962 of the TET2 protein (p.Pro1962Leu). This variant is present in population databases (rs200971953, gnomAD 0.06%), and has an allele count higher than expected for a pathogenic variant. This missense change has been observed in individual(s) with clinical features of acute myeloid leukemia or myelodysplastic syndrome (PMID: 22390313, 32098966). ClinVar contains an entry for this variant (Variation ID: 135294). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2022 | TET2: PM2:Supporting, BP4 - |
not specified Other:1
not provided, no classification provided | reference population | ITMI | Sep 19, 2013 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at